Original Article
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastrointest Endosc. Jun 16, 2014; 6(6): 240-247
Published online Jun 16, 2014. doi: 10.4253/wjge.v6.i6.240
Table 1 Patient characteristics
H-groupM-groupL-groupP value
No. of patients14819
Gender (male/female)9/56/216/30.429
Age (yr)71.5 ± 11.771.6 ± 8.969.9 ± 7.00.569
(range)(40-84)(58-86)(58-81)
Body weight (kg)57.3 ± 10.662.4 ± 10.058.8 ± 8.70.443
(range)(43.1-82)(49-80.3)(44-76)
No. of tumors14819
Location U/M/L1/5/80/2/63/6/100.464
Less, post/great, ant9/53/510/90.485
Resected tumor size (mm)29.0 ± 10.029.3 ± 12.730.2 ± 11.40.827
(range)(15-49)(17-58)(12-50)
Procedure time (min)78.0 ± 54.192.5 ± 55.973.7 ± 46.80.717
(range)(35-240)(35-200)(20-205)
Table 2 Body movement during salivary amylase activity elevation
H-groupM-groupL-groupP value
No. of patients14819
No. of elevated sAMY (times)263016
≥ twice the actual value26110
< twice the actual value01916
with body movement171660.215 (10.078)
without body movement91410
Table 3 Technical status during salivary amylase activity elevation
H-groupL-groupP value
No. of elevated sAMY (times)2616
Operative techniques
Incision940.430
Dissection1110
Hemostasis62
Endoscopic direction
Straight1260.582
Inversion1410
Forceful endoscopic insertion or over insufflation
Presence2290.042
Absence47
Table 4 Interventions used to treat salivary amylase activity elevation and the improvement in terms of body movement [number of episodes of salivary amylase activity elevation/recovery rate of salivary amylase activity (%)]
Body movementPresenceAbsence
Number (times)179
Release of gastric wall tension only2/86.25/66.1
Medication (pentazocine injection) only12/94.73/95.9
Release and medication (pentazocine)2/119.60/-
Medication (midazolam or propofol injection) only1/124.21/85.6